Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $185,699 | 121 | 73.9% |
| Food and Beverage | $29,958 | 1,335 | 11.9% |
| Travel and Lodging | $25,255 | 105 | 10.0% |
| Honoraria | $5,250 | 3 | 2.1% |
| Consulting Fee | $5,060 | 6 | 2.0% |
| Education | $161.99 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $84,724 | 191 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $50,451 | 142 | $0 (2024) |
| ABBVIE INC. | $35,402 | 133 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $16,694 | 40 | $0 (2022) |
| Neurelis, Inc. | $15,577 | 67 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $14,638 | 31 | $0 (2021) |
| Allergan, Inc. | $9,590 | 44 | $0 (2021) |
| PORTOLA PHARMACEUTICALS, LLC | $5,782 | 11 | $0 (2020) |
| UCB, Inc. | $1,435 | 67 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,263 | 100 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,660 | 140 | Neurelis, Inc. ($4,235) |
| 2023 | $25,009 | 170 | ABBVIE INC. ($8,459) |
| 2022 | $34,820 | 218 | Biohaven Pharmaceutical Holding Company Ltd. ($16,694) |
| 2021 | $38,455 | 270 | Biohaven Pharmaceuticals, Inc. ($13,482) |
| 2020 | $41,336 | 198 | Supernus Pharmaceuticals, Inc. ($15,186) |
| 2019 | $30,690 | 248 | Teva Pharmaceuticals USA, Inc. ($17,987) |
| 2018 | $34,855 | 175 | Supernus Pharmaceuticals, Inc. ($22,021) |
| 2017 | $35,558 | 156 | Supernus Pharmaceuticals, Inc. ($34,103) |
All Payment Transactions
1,575 individual payment records from CMS Open Payments — Page 1 of 63
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: EPILEPSY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $3.44 | General |
| Category: Neurology | ||||||
| 12/09/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 12/09/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $1.64 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: Rare Disease | ||||||
| 12/04/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $32.10 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $34.61 | General |
| Category: Neurology | ||||||
| 12/01/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Neurology | ||||||
| 11/27/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: EPILEPSY | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $1.87 | General |
| Category: Neurology | ||||||
| 11/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,272.00 | General |
| Category: EPILEPSY | ||||||
| 11/07/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $56.45 | General |
| 11/07/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Neurology | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: PAIN | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $31.53 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Neurology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $1.82 | General |
| Category: Neurology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $0.28 | General |
| Category: Neurology | ||||||
| 10/25/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 822 | 1,426 | $327,686 | $145,414 |
| 2022 | 21 | 1,405 | 2,966 | $621,343 | $296,571 |
| 2021 | 22 | 1,646 | 3,151 | $662,143 | $307,403 |
| 2020 | 18 | 1,085 | 1,950 | $435,340 | $169,233 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 270 | 649 | $146,025 | $86,720 | 59.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 78 | 78 | $27,300 | $13,626 | 49.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 92 | 98 | $41,650 | $13,220 | 31.7% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 43 | 116 | $44,850 | $8,683 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 54 | $11,880 | $5,300 | 44.6% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2023 | 34 | 42 | $9,240 | $4,741 | 51.3% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 50 | 137 | $17,810 | $4,505 | 25.3% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 45 | 46 | $8,740 | $3,341 | 38.2% |
| 92542 | Test for abnormal eye movement using 3 positions with recording | Office | 2023 | 39 | 50 | $5,900 | $1,212 | 20.5% |
| 92285 | Photography of content of eyes | Office | 2023 | 40 | 53 | $4,505 | $1,116 | 24.8% |
| 92541 | Test for abnormal eye movement with recording | Office | 2023 | 39 | 51 | $5,916 | $1,080 | 18.2% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 26 | 27 | $1,620 | $965.19 | 59.6% |
| 95992 | Repositioning exercises of head for treatment of dizziness, each day | Office | 2023 | 20 | 25 | $2,250 | $906.47 | 40.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 359 | 1,225 | $275,625 | $176,681 | 64.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 146 | 146 | $51,100 | $26,198 | 51.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 117 | 117 | $49,725 | $18,730 | 37.7% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2022 | 48 | 194 | $75,800 | $16,997 | 22.4% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2022 | 70 | 123 | $27,060 | $14,230 | 52.6% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 73 | 248 | $32,240 | $8,270 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 61 | $13,420 | $6,403 | 47.7% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2022 | 78 | 79 | $15,010 | $6,181 | 41.2% |
| 92285 | Photography of content of eyes | Office | 2022 | 76 | 158 | $13,430 | $3,336 | 24.8% |
| 92542 | Test for abnormal eye movement using 3 positions with recording | Office | 2022 | 72 | 127 | $14,986 | $3,217 | 21.5% |
| 95992 | Repositioning exercises of head for treatment of dizziness, each day | Office | 2022 | 38 | 86 | $7,740 | $3,194 | 41.3% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 63 | 76 | $4,560 | $3,046 | 66.8% |
About Dr. Monali Patel, M.D
Dr. Monali Patel, M.D is a Neurology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1326290339.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Monali Patel, M.D has received a total of $251,383 in payments from pharmaceutical and medical device companies, with $10,660 received in 2024. These payments were reported across 1,575 transactions from 83 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($185,699).
As a Medicare-enrolled provider, Patel has provided services to 4,958 Medicare beneficiaries, totaling 9,493 services with total Medicare billing of $918,621. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location San Diego, CA
- Active Since 10/21/2008
- Last Updated 05/03/2018
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1326290339
Products in Payments
- OXTELLAR XR (Drug) $72,943
- UBRELVY (Drug) $34,232
- NURTEC ODT (Drug) $31,559
- AJOVY (Drug) $25,002
- VALTOCO (Drug) $15,577
- AJOVY (Biological) $12,773
- TROKENDI XR (Drug) $11,769
- QULIPTA (Drug) $10,132
- ANDEXXA (Biological) $5,805
- Austedo XR (Drug) $4,529
- AUSTEDO (Drug) $3,967
- Briviact (Drug) $1,080
- VNS Therapy (Device) $875.57
- VYEPTI (Biological) $792.74
- Aimovig (Biological) $773.56
- Andexxa (Drug) $750.00
- Fycompa (Drug) $652.31
- TYSABRI (Biological) $634.25
- GOCOVRI (Drug) $632.79
- KESIMPTA (Drug) $593.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in San Diego
Dr. Revere Kinkel, M.d, M.D
Neurology — Payments: $432,113
Dr. Hossein Ansari, M.d, M.D
Neurology — Payments: $431,759
Nathaniel Schuster, M.d, M.D
Neurology — Payments: $313,162
Jennifer Graves, Md, MD
Neurology — Payments: $138,828
Dr. Jose Soria-Lopez, Md, MD
Neurology — Payments: $108,135
Dr. Royya Modir, M.d, M.D
Neurology — Payments: $101,774